v3.26.1
Segment Reporting
12 Months Ended
Dec. 31, 2025
Segment Reporting  
Segment Reporting

Note 18 – Segment Reporting

The Company has one reportable segment managed on a consolidated basis by the Chief Executive Officer (CEO), who is the chief operating decision maker (“CODM”). In identifying one reportable segment, the Company considered the basis of organization for the design and development and commercialization of ablation technologies for the treatment of cardiac arrhythmias.

 

The accounting policies of the segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance and decides how to allocate resources based on consolidated net loss as reported in the consolidated statements of operations and comprehensive loss. There are no other expense categories regularly provided to the CODM that are not already included in the consolidated statements of operations and comprehensive loss. The measure of segment assets is reported on the consolidated balance sheet as total consolidated assets.

Summary of segment net loss, including significant segment expenses were as follows:

Year Ended December 31, 

2025

2024

Successor

Successor

Predecessor

   

July 31 to December 31

January 1 to July 30

Revenue

$

$

269

$

333

Less:

Cost of revenue

684

1,937

1,381

Research and development

10,639

4,634

7,585

Selling, general, and administrative

10,567

6,976

13,047

Impairment - Goodwill

30,324

Impairment - Intangible assets, net

18,878

Other income (expense), net

(3,194)

8,717

402

Net loss

$

(25,084)

$

(53,763)

$

(21,278)